Viewing Study NCT00346294


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-06-30 @ 8:00 AM
Study NCT ID: NCT00346294
Status: COMPLETED
Last Update Posted: 2020-01-22
First Post: 2006-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Device View
None Auto-injector View
None SureClick View
None Enbrel View
None Etanercept View